Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Stem Cell Therapy in Injured Vocal Folds: A Three-Month Xenograft Analysis of Human Embryonic Stem Cells
Umeå University, Faculty of Medicine, Department of Public Health and Clinical Medicine. Department of Otorhinolaryngology, Östersund, Sweden. (Unit of Clinical Research Center)
Show others and affiliations
2015 (English)In: BioMed Research International, ISSN 2314-6133, E-ISSN 2314-6141, 754876Article in journal (Refereed) Published
Abstract [en]

We have previously shown that human embryonic stem cell (hESC) therapy to injured rabbit vocal folds (VFs) induces human tissue generation with regained VF vibratory capacity. The aims of this study were to test the sustainability of such effect and to what extent derivatives of the transplanted hESCs are propagated in the VFs. The VFs of 14 New Zealand rabbits were injured by a localized resection. HESCs were transplanted to 22 VFs which were analyzed for persistence of hESCs after six weeks and after three months. At three months, the VFs were also analyzed for viscoelasticity, measured as dynamic viscosity and elastic modulus, for the lamina propria (Lp) thickness and relative content of collagen type I. Three months after hESC cell therapy, the dynamic viscosity and elastic modulus of the hESC treated VFs were similar to normal controls and lower than untreated VFs (P <= 0.011). A normalized VF architecture, reduction in collagen type I, and Lp thickness were found compared with untreated VFs (P <= 0.031). At three months, no derivatives of hESCs were detected. HESCs transplanted to injured rabbit VFs restored the vibratory characteristics of the VFs, with maintained restored function for three months without remaining hESCs or derivatives.

Place, publisher, year, edition, pages
2015. 754876
National Category
Otorhinolaryngology Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)
Identifiers
URN: urn:nbn:se:umu:diva-112021DOI: 10.1155/2015/754876ISI: 000364082500001OAI: oai:DiVA.org:umu-112021DiVA: diva2:875003
Available from: 2015-11-30 Created: 2015-11-30 Last updated: 2017-12-01Bibliographically approved

Open Access in DiVA

fulltext(2755 kB)35 downloads
File information
File name FULLTEXT01.pdfFile size 2755 kBChecksum SHA-512
3be4598336d7ce5301bb19760668be62cbdcd57a3adf1f16cda8aa9eb8f02c2d92d0ef5b4ffe76efc636cd35271a42cd5b14f0586145fa9269a8c4031526c49a
Type fulltextMimetype application/pdf

Other links

Publisher's full text
By organisation
Department of Public Health and Clinical Medicine
In the same journal
BioMed Research International
OtorhinolaryngologyMedical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)

Search outside of DiVA

GoogleGoogle Scholar
Total: 35 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 52 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf